Cargando…

Selective vulnerability of inhibitory networks in multiple sclerosis

In multiple sclerosis (MS), a chronic demyelinating disease of the central nervous system, neurodegeneration is detected early in the disease course and is associated with the long-term disability of patients. Neurodegeneration is linked to both inflammation and demyelination, but its exact cause re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoupi, Lida, Booker, Sam A., Eigel, Dimitri, Werner, Carsten, Kind, Peter C., Spires-Jones, Tara L., Newland, Ben, Williams, Anna C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882577/
https://www.ncbi.nlm.nih.gov/pubmed/33449171
http://dx.doi.org/10.1007/s00401-020-02258-z
_version_ 1783651078317801472
author Zoupi, Lida
Booker, Sam A.
Eigel, Dimitri
Werner, Carsten
Kind, Peter C.
Spires-Jones, Tara L.
Newland, Ben
Williams, Anna C.
author_facet Zoupi, Lida
Booker, Sam A.
Eigel, Dimitri
Werner, Carsten
Kind, Peter C.
Spires-Jones, Tara L.
Newland, Ben
Williams, Anna C.
author_sort Zoupi, Lida
collection PubMed
description In multiple sclerosis (MS), a chronic demyelinating disease of the central nervous system, neurodegeneration is detected early in the disease course and is associated with the long-term disability of patients. Neurodegeneration is linked to both inflammation and demyelination, but its exact cause remains unknown. This gap in knowledge contributes to the current lack of treatments for the neurodegenerative phase of MS. Here we ask if neurodegeneration in MS affects specific neuronal components and if it is the result of demyelination. Neuropathological examination of secondary progressive MS motor cortices revealed a selective vulnerability of inhibitory interneurons in MS. The generation of a rodent model of focal subpial cortical demyelination reproduces this selective neurodegeneration providing a new preclinical model for the study of neuroprotective treatments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-020-02258-z.
format Online
Article
Text
id pubmed-7882577
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78825772021-02-25 Selective vulnerability of inhibitory networks in multiple sclerosis Zoupi, Lida Booker, Sam A. Eigel, Dimitri Werner, Carsten Kind, Peter C. Spires-Jones, Tara L. Newland, Ben Williams, Anna C. Acta Neuropathol Original Paper In multiple sclerosis (MS), a chronic demyelinating disease of the central nervous system, neurodegeneration is detected early in the disease course and is associated with the long-term disability of patients. Neurodegeneration is linked to both inflammation and demyelination, but its exact cause remains unknown. This gap in knowledge contributes to the current lack of treatments for the neurodegenerative phase of MS. Here we ask if neurodegeneration in MS affects specific neuronal components and if it is the result of demyelination. Neuropathological examination of secondary progressive MS motor cortices revealed a selective vulnerability of inhibitory interneurons in MS. The generation of a rodent model of focal subpial cortical demyelination reproduces this selective neurodegeneration providing a new preclinical model for the study of neuroprotective treatments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-020-02258-z. Springer Berlin Heidelberg 2021-01-15 2021 /pmc/articles/PMC7882577/ /pubmed/33449171 http://dx.doi.org/10.1007/s00401-020-02258-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Zoupi, Lida
Booker, Sam A.
Eigel, Dimitri
Werner, Carsten
Kind, Peter C.
Spires-Jones, Tara L.
Newland, Ben
Williams, Anna C.
Selective vulnerability of inhibitory networks in multiple sclerosis
title Selective vulnerability of inhibitory networks in multiple sclerosis
title_full Selective vulnerability of inhibitory networks in multiple sclerosis
title_fullStr Selective vulnerability of inhibitory networks in multiple sclerosis
title_full_unstemmed Selective vulnerability of inhibitory networks in multiple sclerosis
title_short Selective vulnerability of inhibitory networks in multiple sclerosis
title_sort selective vulnerability of inhibitory networks in multiple sclerosis
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882577/
https://www.ncbi.nlm.nih.gov/pubmed/33449171
http://dx.doi.org/10.1007/s00401-020-02258-z
work_keys_str_mv AT zoupilida selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis
AT bookersama selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis
AT eigeldimitri selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis
AT wernercarsten selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis
AT kindpeterc selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis
AT spiresjonestaral selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis
AT newlandben selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis
AT williamsannac selectivevulnerabilityofinhibitorynetworksinmultiplesclerosis